SEC Form 4 · accession 0001615774-17-005848
Zynerba Pharmaceuticals, Inc. · ZYNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Rapp
10% Owner
Period of report
Oct 19, 2017
Accepted (ET)
Oct 23, 2017 · 7:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001621443
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 19, 2017 | P | 44,255 | $9.59 | A | 1,398,370 | D | |
| Common StockF1 | Oct 20, 2017 | P | 30,000 | $9.7846 | A | 1,428,370 | D | |
| Common StockF1 | Oct 23, 2017 | P | 25,745 | $9.9357 | A | 1,454,115 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 80,467 shares transferred by Broadband Capital Management LLC ("BCM") to Reporting Person for no consideration. The Reporting Person was the Chairman and member of BCM.